CompletedNot applicableNCT02826694
North Carolina Newborn Exome Sequencing for Universal Screening
Studying Genetic otorhinolaryngologic disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Jonathan Berg, MD, PhDUniversity of North Carolina School of Medicine Department of Genetics
- Intervention
- Well infant, whole exome sequencing(genetic)
- Enrollment
- 106 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2016 – 2019
Study locations (1)
- UNC Hospitals, Chapel Hill, North Carolina, United States
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · National Human Genome Research Institute (NHGRI) · RTI International
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02826694 on ClinicalTrials.govOther trials for Genetic otorhinolaryngologic disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07525505Nigella Sativa Oil for Eczematous Otitis ExternaBezmialem Vakif University
- RECRUITINGNCT07518069Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With PhenotypesIRCCS San Raffaele
- ACTIVE NOT RECRUITINGNCT06133946Cohort Of DEafness-gene ScreeningAffiliated Hospital of Nantong University